Hospital Stocks CRASH! Supreme Court Questions ON!

HOSPITAL RISK-->“Sarkari Hospital Mein Jaan Ka Risk… Private Hospital Mein Jameen-Jaydaad Ka Risk!” erns over steep mark-ups on medicines sold through private hospitals. Stocks including

, Max Healthcare, Fortis Healthcare, Yatharth Hospital, Medanta and Aster DM came under pressure, with several names falling sharply during the session. --->What Did the Supreme Court Question? The Supreme Court was hearing petitions related to medicine pricing, generic prescriptions and medical-device pricing under the Drugs (Prices Control) Order, 2013. During the hearing, the bench highlighted a striking example: A cancer medicine supplied to retailers for around ₹2,700 was cited as carrying an MRP of around ₹27,000. The Court questioned how such a large gap could exist and also raised concerns about hospitals requiring patients to purchase medicines through their own or designated pharmacies. ---->Why Are Hospital Stocks Falling? The market is worried about one simple issue: Medicine mark-ups can be an important part of hospital economics. If hospitals are eventually required to operate with significantly lower medicine margins, it could potentially affect: • Pharmacy-related revenue • EBITDA margins • Profitability • Revenue per patient ---->The 16% Rule — Don't Misunderstand It This is where the headlines can become misleading. The Supreme Court questioned whether a uniform 16% margin could be applied more broadly. But: The Court has NOT ordered a universal 16% cap on all medicines. The existing 16% retailer-margin concept is already used in parts of India's drug-price-control framework for scheduled formulations. ---->Bottom Line Hospital stocks are falling because the Supreme Court has put hospital medicine mark-ups and captive pharmacy practices under the regulatory spotlight. The market is currently pricing in the risk of tighter regulation, not a confirmed 16% margin cap.